Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» FDA asks Arrowhead to cut Hep B drug dosage in mid-stage trial
FDA asks Arrowhead to cut Hep B drug dosage in mid-stage trial
FDA asks Arrowhead to cut Hep B drug dosage in mid-stage trial
Submitted by
admin
on January 12, 2015 - 8:42am
Source:
Reuters
News Tags:
FDA
hepatitis B
Arrowhead Research
clinical trials
Headline:
FDA asks Arrowhead to cut Hep B drug dosage in mid-stage trial
Do Not Allow Advertisers to Use My Personal information
